Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
CORV was delisted on the 26th of May, 2020.
33 hedge funds and large institutions have $62M invested in Correvio Pharma Corp. Ordinary Shares (Canada) in 2016 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 15 increasing their positions, 4 reducing their positions, and 4 closing their positions.
275% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 4
75% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 4
10% more funds holding
Funds holding: 30 → 33 (+3)
1% more capital invested
Capital invested by funds: $61.6M → $62M (+$395K)
100% less call options, than puts
Call options by funds: $1K | Put options by funds: $360K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TA
Tamarack Advisers
Carlsbad,
California
|
+$8.02M |
| 2 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$7M |
| 3 |
Westfield Capital Management
Boston,
Massachusetts
|
+$5.42M |
| 4 |
CCP
Clough Capital Partners
Boston,
Massachusetts
|
+$3.65M |
| 5 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$2.91M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TI
Turner Investments
Berwyn,
Pennsylvania
|
-$911K |
| 2 |
Mackenzie Financial
Toronto Ontario,
Ontario, Canada
|
-$391K |
| 3 |
CAM
ClariVest Asset Management
San Diego,
California
|
-$109K |
| 4 |
ARTA
A.R.T. Advisors
New York
|
-$70K |
| 5 |
Walleye Trading
New York
|
-$26K |
CORV Hedge Fund Activity: Q3 2016 in Review
33 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) for Q3 2016, worth a combined $62M — up 0.64% from $61.6M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new CORV positions and 4 closed out — a net gain of 3 holders — while 15 added to existing stakes and 4 trimmed.
The largest buyer was Tamarack Advisers, opening a new position worth an estimated $8.02M. The largest seller was Turner Investments, cutting an estimated $911K.
- 33 institutional investors held Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) as of Q3 2016, up from 30 in Q2 2016.
- Funds reported $62M of Correvio Pharma Corp. Ordinary Shares (Canada) stock for Q3 2016, up 0.64% quarter-over-quarter.
- 7 funds opened new Correvio Pharma Corp. Ordinary Shares (Canada) positions in Q3 2016 and 4 closed out, a net change of +3 holders.
- The largest Correvio Pharma Corp. Ordinary Shares (Canada) buyer in Q3 2016 was Tamarack Advisers, an estimated $8.02M added.
- The largest Correvio Pharma Corp. Ordinary Shares (Canada) seller in Q3 2016 was Turner Investments, an estimated $911K sold.
Based on aggregated 13F filings for Q3 2016.